Aida Pharmaceuticals, Inc. (AIDA)

0.0002 0.0000 (0.00%) At close: 11:32AM EDT

Aida Pharmaceuticals, Inc.

31 Dingjiang Road
Jianggan District
Hangzhou 310016
China
86 571 8580 2712

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 450

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Biao Jin	Chairman and Chief Executive Officer	19.06k	N/A	1948
Ms. Lin Hui	Chief Financial Officer and Principal Accounting Officer	12.7k	N/A	1966
Mr. Yue Jun Jiang	Chief of Investment Department and Secretary	N/A	N/A	1975
Mr. Qiu Jiajun	Member of Compensation Committee and Director	N/A	N/A	1966

Amounts are as of 31 December 2007, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.

Corporate governance

Aida Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.